110 related articles for article (PubMed ID: 16179515)
1. Effect of neuroprotective drugs on gene expression in G93A/SOD1 mice.
Ignacio S; Moore DH; Smith AP; Lee NM
Ann N Y Acad Sci; 2005 Aug; 1053():121-36. PubMed ID: 16179515
[TBL] [Abstract][Full Text] [Related]
2. Metallothionein expression is altered in a transgenic murine model of familial amyotrophic lateral sclerosis.
Gong YH; Elliott JL
Exp Neurol; 2000 Mar; 162(1):27-36. PubMed ID: 10716886
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of metallothionein-I, a copper-regulating protein, attenuates intracellular copper dyshomeostasis and extends lifespan in a mouse model of amyotrophic lateral sclerosis caused by mutant superoxide dismutase-1.
Tokuda E; Okawa E; Watanabe S; Ono S
Hum Mol Genet; 2014 Mar; 23(5):1271-85. PubMed ID: 24163136
[TBL] [Abstract][Full Text] [Related]
4. Temporal gene expression patterns in G93A/SOD1 mouse.
Chen LC; Smith A; Ben Y; Zukic B; Ignacio S; Moore D; Lee N
Amyotroph Lateral Scler Other Motor Neuron Disord; 2004 Sep; 5(3):164-71. PubMed ID: 15512905
[TBL] [Abstract][Full Text] [Related]
5. Stabilization of mutant Cu/Zn superoxide dismutase (SOD1) protein by coexpressed wild SOD1 protein accelerates the disease progression in familial amyotrophic lateral sclerosis mice.
Fukada K; Nagano S; Satoh M; Tohyama C; Nakanishi T; Shimizu A; Yanagihara T; Sakoda S
Eur J Neurosci; 2001 Dec; 14(12):2032-6. PubMed ID: 11860498
[TBL] [Abstract][Full Text] [Related]
6. Disease progression in a transgenic model of familial amyotrophic lateral sclerosis is dependent on both neuronal and non-neuronal zinc binding proteins.
Puttaparthi K; Gitomer WL; Krishnan U; Son M; Rajendran B; Elliott JL
J Neurosci; 2002 Oct; 22(20):8790-6. PubMed ID: 12388585
[TBL] [Abstract][Full Text] [Related]
7. C/EBPβ expression in activated microglia in amyotrophic lateral sclerosis.
Valente T; Mancera P; Tusell JM; Serratosa J; Saura J
Neurobiol Aging; 2012 Sep; 33(9):2186-99. PubMed ID: 22015310
[TBL] [Abstract][Full Text] [Related]
8. Metallothionein proteins expression, copper and zinc concentrations, and lipid peroxidation level in a rodent model for amyotrophic lateral sclerosis.
Tokuda E; Ono S; Ishige K; Naganuma A; Ito Y; Suzuki T
Toxicology; 2007 Jan; 229(1-2):33-41. PubMed ID: 17097207
[TBL] [Abstract][Full Text] [Related]
9. Cu/Zn superoxide dismutase (SOD1) mutations associated with familial amyotrophic lateral sclerosis (ALS) affect cellular free radical release in the presence of oxidative stress.
Cookson MR; Menzies FM; Manning P; Eggett CJ; Figlewicz DA; McNeil CJ; Shaw PJ
Amyotroph Lateral Scler Other Motor Neuron Disord; 2002 Jun; 3(2):75-85. PubMed ID: 12215229
[TBL] [Abstract][Full Text] [Related]
10. Clemastine Confers Neuroprotection and Induces an Anti-Inflammatory Phenotype in SOD1(G93A) Mouse Model of Amyotrophic Lateral Sclerosis.
Apolloni S; Fabbrizio P; Parisi C; Amadio S; Volonté C
Mol Neurobiol; 2016 Jan; 53(1):518-531. PubMed ID: 25482048
[TBL] [Abstract][Full Text] [Related]
11. Muscle-derived but not centrally derived transgene GDNF is neuroprotective in G93A-SOD1 mouse model of ALS.
Li W; Brakefield D; Pan Y; Hunter D; Myckatyn TM; Parsadanian A
Exp Neurol; 2007 Feb; 203(2):457-71. PubMed ID: 17034790
[TBL] [Abstract][Full Text] [Related]
12. Temporal patterns of cytokine and apoptosis-related gene expression in spinal cords of the G93A-SOD1 mouse model of amyotrophic lateral sclerosis.
Hensley K; Floyd RA; Gordon B; Mou S; Pye QN; Stewart C; West M; Williamson K
J Neurochem; 2002 Jul; 82(2):365-74. PubMed ID: 12124437
[TBL] [Abstract][Full Text] [Related]
13. DL-3-n-butylphthalide extends survival by attenuating glial activation in a mouse model of amyotrophic lateral sclerosis.
Feng X; Peng Y; Liu M; Cui L
Neuropharmacology; 2012 Feb; 62(2):1004-10. PubMed ID: 22056419
[TBL] [Abstract][Full Text] [Related]
14. Differential expression of inflammation- and apoptosis-related genes in spinal cords of a mutant SOD1 transgenic mouse model of familial amyotrophic lateral sclerosis.
Yoshihara T; Ishigaki S; Yamamoto M; Liang Y; Niwa J; Takeuchi H; Doyu M; Sobue G
J Neurochem; 2002 Jan; 80(1):158-67. PubMed ID: 11796754
[TBL] [Abstract][Full Text] [Related]
15. Increased expression of the glial glutamate transporter EAAT2 modulates excitotoxicity and delays the onset but not the outcome of ALS in mice.
Guo H; Lai L; Butchbach ME; Stockinger MP; Shan X; Bishop GA; Lin CL
Hum Mol Genet; 2003 Oct; 12(19):2519-32. PubMed ID: 12915461
[TBL] [Abstract][Full Text] [Related]
16. Neuronal nitric oxide synthase (nNOS) immunoreactivity in the spinal cord of transgenic mice with G93A mutant SOD1 gene.
Sasaki S; Warita H; Abe K; Iwata M
Acta Neuropathol; 2002 May; 103(5):421-7. PubMed ID: 11935256
[TBL] [Abstract][Full Text] [Related]
17. Cromolyn sodium delays disease onset and is neuroprotective in the SOD1
Granucci EJ; Griciuc A; Mueller KA; Mills AN; Le H; Dios AM; McGinty D; Pereira J; Elmaleh D; Berry JD; Paganoni S; Cudkowicz ME; Tanzi RE; Sadri-Vakili G
Sci Rep; 2019 Nov; 9(1):17728. PubMed ID: 31776380
[TBL] [Abstract][Full Text] [Related]
18. On the relation of oxidative stress to neuroinflammation: lessons learned from the G93A-SOD1 mouse model of amyotrophic lateral sclerosis.
Hensley K; Mhatre M; Mou S; Pye QN; Stewart C; West M; Williamson KS
Antioxid Redox Signal; 2006; 8(11-12):2075-87. PubMed ID: 17034351
[TBL] [Abstract][Full Text] [Related]
19. The anti-inflammatory peptide stearyl-norleucine-VIP delays disease onset and extends survival in a rat model of inherited amyotrophic lateral sclerosis.
Goursaud S; Schäfer S; Dumont AO; Vergouts M; Gallo A; Desmet N; Deumens R; Hermans E
Exp Neurol; 2015 Jan; 263():91-101. PubMed ID: 25311268
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic immunization with a glatiramer acetate derivative does not alter survival in G93A and G37R SOD1 mouse models of familial ALS.
Haenggeli C; Julien JP; Mosley RL; Perez N; Dhar A; Gendelman HE; Rothstein JD
Neurobiol Dis; 2007 Apr; 26(1):146-52. PubMed ID: 17276077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
